A Study of TAK-071 in People With Parkinson Disease
Public ClinicalTrials.gov record NCT04334317. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-Controlled, 2-Period Crossover, Phase 2 Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral TAK-071 in Parkinson Disease Patients With Cognitive Impairment and an Elevated Risk of Falls
Study identification
- NCT ID
- NCT04334317
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Takeda
- Industry
- Enrollment
- 64 participants
Conditions and interventions
Conditions
Interventions
- TAK-071 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 40 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 20, 2020
- Primary completion
- Feb 26, 2023
- Completion
- Feb 26, 2023
- Last update posted
- May 13, 2024
2020 – 2023
United States locations
- U.S. sites
- 21
- U.S. states
- 15
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Collaborative Neuroscience Network, LLC | Garden Grove | California | 92845 | — |
| University of California Irvine Medical Center | Irvine | California | 92697 | — |
| Cedars Sinai Medical Center | Los Angeles | California | 90048 | — |
| Rocky Mountain Movement Disorders Center | Englewood | Colorado | 80113 | — |
| PPD Phase 1 Clinic | Orlando | Florida | 32806 | — |
| Infinity Clinical Research, LLC | Sunrise | Florida | 33351 | — |
| USF Medical Clinic | Tampa | Florida | 33612 | — |
| Augusta University | Augusta | Georgia | 30912 | — |
| Feinberg School of Medicine Northwestern University | Chicago | Illinois | 60611 | — |
| Indiana University Health Neuroscience Center | Indianapolis | Indiana | 46202 | — |
| Quest Research Institute - Hunt - PPDS | Farmington Hills | Michigan | 48334 | — |
| Park Nicollet Health Services | Golden Valley | Minnesota | 55427 | — |
| University of Rochester Medicine - Movement Disorders Unit | Rochester | New York | 14618 | — |
| Neurology Diagnostics, Inc. - ERG - PPDS | Dayton | Ohio | 45459 | — |
| University of Philadelphia | Philadelphia | Pennsylvania | 19107 | — |
| Medical University of South Carolina - PPDS | Charleston | South Carolina | 29425 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
| Central Texas Neurology | Round Rock | Texas | 78681 | — |
| Meridian Clinical Research | Norfolk | Virginia | 23502 | — |
| Evergreen Hospital Medical Center | Kirkland | Washington | 98034 | — |
| Inland Northwest Research | Spokane | Washington | 99202-6290 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04334317, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 13, 2024 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04334317 live on ClinicalTrials.gov.